ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy.
Saved in:
| Title: | ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy. |
|---|---|
| Authors: | Liu S; Department of Breast Medical Oncology, USA. Electronic address: sliu@mdanderson.org., Chen H; Department of Breast Medical Oncology, USA; Department of of Biostatistics, USA., Gagea M; Department of Veterinary Medicine and Surgery, USA., Federico L; Department of System Biology, USA., Zhang F; Department of System Biology, USA., Gomez J; Department of Leukemia, USA., Do KA; Department of of Biostatistics, USA., Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hortobagyi GN; Department of Breast Medical Oncology, USA., Mills GB; Department of System Biology, USA., Gonzalez-Angulo AM; Department of Breast Medical Oncology, USA., Tripathy D; Department of Breast Medical Oncology, USA. |
| Source: | Cancer letters [Cancer Lett] 2025 Aug 28; Vol. 626, pp. 217775. Date of Electronic Publication: 2025 May 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40339955 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liu+S%22">Liu S</searchLink>; Department of Breast Medical Oncology, USA. Electronic address: sliu@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; Department of Breast Medical Oncology, USA; Department of of Biostatistics, USA.<br /><searchLink fieldCode="AU" term="%22Gagea+M%22">Gagea M</searchLink>; Department of Veterinary Medicine and Surgery, USA.<br /><searchLink fieldCode="AU" term="%22Federico+L%22">Federico L</searchLink>; Department of System Biology, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+F%22">Zhang F</searchLink>; Department of System Biology, USA.<br /><searchLink fieldCode="AU" term="%22Gomez+J%22">Gomez J</searchLink>; Department of Leukemia, USA.<br /><searchLink fieldCode="AU" term="%22Do+KA%22">Do KA</searchLink>; Department of of Biostatistics, USA.<br /><searchLink fieldCode="AU" term="%22Symmans+WF%22">Symmans WF</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hortobagyi+GN%22">Hortobagyi GN</searchLink>; Department of Breast Medical Oncology, USA.<br /><searchLink fieldCode="AU" term="%22Mills+GB%22">Mills GB</searchLink>; Department of System Biology, USA.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Angulo+AM%22">Gonzalez-Angulo AM</searchLink>; Department of Breast Medical Oncology, USA.<br /><searchLink fieldCode="AU" term="%22Tripathy+D%22">Tripathy D</searchLink>; Department of Breast Medical Oncology, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227600053%22">Cancer letters</searchLink> [Cancer Lett] 2025 Aug 28; Vol. 626, pp. 217775. <i>Date of Electronic Publication: </i>2025 May 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ireland%22">Elsevier Science Ireland </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>7600053 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7980 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203043835%22">03043835 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Lett <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40339955 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.canlet.2025.217775 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 217775 Titles: – TitleFull: ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu S – PersonEntity: Name: NameFull: Chen H – PersonEntity: Name: NameFull: Gagea M – PersonEntity: Name: NameFull: Federico L – PersonEntity: Name: NameFull: Zhang F – PersonEntity: Name: NameFull: Gomez J – PersonEntity: Name: NameFull: Do KA – PersonEntity: Name: NameFull: Symmans WF – PersonEntity: Name: NameFull: Hortobagyi GN – PersonEntity: Name: NameFull: Mills GB – PersonEntity: Name: NameFull: Gonzalez-Angulo AM – PersonEntity: Name: NameFull: Tripathy D IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 08 Text: 2025 Aug 28 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1872-7980 Numbering: – Type: volume Value: 626 Titles: – TitleFull: Cancer letters Type: main |
| ResultId | 1 |